Literature DB >> 25959410

Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.

Martine Tetreault1, Eric Bareke, Javad Nadaf, Najmeh Alirezaie, Jacek Majewski.   

Abstract

Whole-exome sequencing (WES) represents a significant breakthrough in the field of human genetics. This technology has largely contributed to the identification of new disease-causing genes and is now entering clinical laboratories. WES represents a powerful tool for diagnosis and could reduce the 'diagnostic odyssey' for many patients. In this review, we present a technical overview of WES analysis, variants annotation and interpretation in a clinical setting. We evaluate the usefulness of clinical WES in different clinical indications, such as rare diseases, cancer and complex diseases. Finally, we discuss the efficacy of WES as a diagnostic tool and the impact on patient management.

Entities:  

Keywords:  cancer; diagnostic; rare diseases; variants detection; whole-exome sequencing

Mesh:

Year:  2015        PMID: 25959410     DOI: 10.1586/14737159.2015.1039516

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  22 in total

1.  Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.

Authors:  Lucía Trilla-Fuertes; Ismael Ghanem; Angelo Gámez-Pozo; Joan Maurel; Laura G-Pastrián; Marta Mendiola; Cristina Peña; Rocío López-Vacas; Guillermo Prado-Vázquez; Elena López-Camacho; Andrea Zapater-Moros; Victoria Heredia; Miriam Cuatrecasas; Pilar García-Alfonso; Jaume Capdevila; Carles Conill; Rocío García-Carbonero; Ricardo Ramos-Ruiz; Claudia Fortes; Carlos Llorens; Paolo Nanni; Juan Ángel Fresno Vara; Jaime Feliu
Journal:  Mol Cell Proteomics       Date:  2020-02-27       Impact factor: 5.911

2.  Exploring the Issues Surrounding Clinical Exome Sequencing in the Prenatal Setting.

Authors:  Swetha Narayanan; Bruce Blumberg; Marla L Clayman; Vivian Pan; Catherine Wicklund
Journal:  J Genet Couns       Date:  2018-03-10       Impact factor: 2.537

Review 3.  Defining the Clinical Value of a Genomic Diagnosis in the Era of Next-Generation Sequencing.

Authors:  Natasha T Strande; Jonathan S Berg
Journal:  Annu Rev Genomics Hum Genet       Date:  2016-05-26       Impact factor: 8.929

4.  Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.

Authors:  Nasim Vasli; Elizabeth Harris; Jason Karamchandani; Eric Bareke; Jacek Majewski; Norma B Romero; Tanya Stojkovic; Rita Barresi; Hichem Tasfaout; Richard Charlton; Edoardo Malfatti; Johann Bohm; Chiara Marini-Bettolo; Karine Choquet; Marie-Josée Dicaire; Yi-Hong Shao; Ana Topf; Erin O'Ferrall; Bruno Eymard; Volker Straub; Gonzalo Blanco; Hanns Lochmüller; Bernard Brais; Jocelyn Laporte; Martine Tétreault
Journal:  Brain       Date:  2016-11-05       Impact factor: 13.501

5.  Molecular characterization of DICER1-mutated pituitary blastoma.

Authors:  Javad Nadaf; Leanne de Kock; Anne-Sophie Chong; Márta Korbonits; Paul Thorner; Naciba Benlimame; Lili Fu; Andrew Peet; Justin Warner; Oswald Ploner; Shanop Shuangshoti; Steffen Albrecht; Nancy Hamel; John R Priest; Barbara Rivera; Jiannis Ragoussis; William D Foulkes
Journal:  Acta Neuropathol       Date:  2021-03-01       Impact factor: 17.088

6.  Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants.

Authors:  Eirwen M Miller; Nicole E Patterson; Jenna Marcus Zechmeister; Michal Bejerano-Sagie; Maria Delio; Kunjan Patel; Nivedita Ravi; Wilber Quispe-Tintaya; Alexander Maslov; Nichelle Simmons; Maria Castaldi; Jan Vijg; Rouzan G Karabakhtsian; John M Greally; Dennis Y S Kuo; Cristina Montagna
Journal:  Oncotarget       Date:  2017-10-26

Review 7.  Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.

Authors:  Kathryn A Phillips; Patricia A Deverka; Harold C Sox; Muin J Khoury; Lewis G Sandy; Geoffrey S Ginsburg; Sean R Tunis; Lori A Orlando; Michael P Douglas
Journal:  Genet Med       Date:  2017-04-13       Impact factor: 8.822

8.  Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.

Authors:  Antonio Pannuti; Aleksandra Filipovic; Chindo Hicks; Elliot Lefkowitz; Travis Ptacek; Justin Stebbing; Lucio Miele
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

9.  Concordance between whole-exome sequencing and clinical Sanger sequencing: implications for patient care.

Authors:  Alison Hamilton; Martine Tétreault; David A Dyment; Ruobing Zou; Kristin Kernohan; Michael T Geraghty; Taila Hartley; Kym M Boycott
Journal:  Mol Genet Genomic Med       Date:  2016-05-10       Impact factor: 2.183

10.  A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome.

Authors:  Roser Urreizti; Sarah Damanti; Carla Esteve; Héctor Franco-Valls; Laura Castilla-Vallmanya; Raul Tonda; Bru Cormand; Lluïsa Vilageliu; John M Opitz; Giovanni Neri; Daniel Grinberg; Susana Balcells
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.